Home News How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say back to News
minute read
Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.
Topics: Press Coverage, DOPS Faculty
12850 East Montview Boulevard
Aurora, CO 80045
303-724-2882
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
